Thierry Bonnevay has more than 25 years of experience in the field of microbiological quality control, acquired
within the Sanofi Vaccine and has held various positions in this field both in industrial affairs and in R&D. He is a member of the European Pharmacopoeia Expert Group EDQM within Group 1 Microbiology
(since 2016), the
Bacterial Endotoxins Working Group (WP BET) since 2017 and the Mycoplasma Working Group (WP MYC) since 2018. Finally, he is part of the board of the French association A3P since 2017.
Read More